139 related articles for article (PubMed ID: 36939694)
1. Serum neurofilament light chain in patients with epilepsy and cognitive impairment.
Ueda M; Suzuki M; Hatanaka M; Nakamura T; Hirayama M; Katsuno M
Epileptic Disord; 2023 Apr; 25(2):229-236. PubMed ID: 36939694
[TBL] [Abstract][Full Text] [Related]
2. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers.
Novobilský R; Bartova P; Lichá K; Bar M; Stejskal D; Kusnierova P
Front Hum Neurosci; 2023; 17():1284416. PubMed ID: 38164192
[TBL] [Abstract][Full Text] [Related]
4. Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia.
Ma W; Zhang J; Xu J; Feng D; Wang X; Zhang F
Dis Markers; 2020; 2020():6612871. PubMed ID: 33204362
[TBL] [Abstract][Full Text] [Related]
5. Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain.
Chen CY; Chiu CC; Huang CY; Cheng YC; Huang MC; Kuo PH; Chen WY
BMC Geriatr; 2024 Apr; 24(1):344. PubMed ID: 38627748
[TBL] [Abstract][Full Text] [Related]
6. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
7. Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients.
Traub J; Otto M; Sell R; Göpfert D; Homola G; Steinacker P; Oeckl P; Morbach C; Frantz S; Pham M; Störk S; Stoll G; Frey A
Alzheimers Res Ther; 2022 Oct; 14(1):149. PubMed ID: 36217177
[TBL] [Abstract][Full Text] [Related]
8. Delirium, neurofilament light chain, and progressive cognitive impairment: analysis of a prospective Norwegian population-based cohort.
Krogseth M; Davis D; Jackson TA; Zetterberg H; Watne LO; Lindberg M; Chitalu P; Tsui A; Selbæk G; Wyller TB
Lancet Healthy Longev; 2023 Aug; 4(8):e399-e408. PubMed ID: 37459878
[TBL] [Abstract][Full Text] [Related]
9. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B
J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777
[TBL] [Abstract][Full Text] [Related]
10. Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study.
Götze K; Vrillon A; Bouaziz-Amar E; Mouton-Liger F; Hugon J; Martinet M; Dumurgier J; Cognat E; Zetterberg H; Blennow K; Hourrègue C; Paquet C; Lilamand M
Neurobiol Dis; 2023 Jan; 176():105937. PubMed ID: 36462720
[TBL] [Abstract][Full Text] [Related]
11. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder.
Requena-Ocaña N; Araos P; Serrano-Castro PJ; Flores-López M; García-Marchena N; Oliver-Martos B; Ruiz JJ; Gavito A; Pavón FJ; Serrano A; Mayoral F; Suarez J; Fonseca FR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674698
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis.
Fan Z; Liu X; Liu J; Chen C; Zhou M
J Integr Neurosci; 2023 Jun; 22(4):85. PubMed ID: 37519166
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
Aamodt WW; Waligorska T; Shen J; Tropea TF; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Xie SX; Trojanowski JQ; Shaw LM; Chen-Plotkin AS
Mov Disord; 2021 Dec; 36(12):2945-2950. PubMed ID: 34480363
[TBL] [Abstract][Full Text] [Related]
14. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
[TBL] [Abstract][Full Text] [Related]
15. Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
Dong L; Chang Q; Ma J; Liu C; Guo D; Li X; Yang D; Fan Y; Liang K; Li D; Gu Q
Neurosci Lett; 2023 May; 804():137219. PubMed ID: 37023526
[TBL] [Abstract][Full Text] [Related]
16. Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease.
Ma LZ; Zhang C; Wang H; Ma YH; Shen XN; Wang J; Tan L; Dong Q; Yu JT
J Parkinsons Dis; 2021; 11(3):1117-1127. PubMed ID: 33935105
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of cerebrospinal fluid amyloid β-protein 42 and neurofilament light protein levels with postoperative neurocognitive dysfunction in elderly patients].
Zhang X; Fu Q
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):574-578. PubMed ID: 33963718
[TBL] [Abstract][Full Text] [Related]
18. Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy.
Orhun G; Esen F; Yilmaz V; Ulusoy C; Şanlı E; Yıldırım E; Gürvit H; Ergin Özcan P; Sencer S; Bebek N; Tüzün E
Int J Neurosci; 2023 Mar; 133(3):327-333. PubMed ID: 33851572
[TBL] [Abstract][Full Text] [Related]
19. Examination of Neurofilament Light Chain Serum Concentrations, Physical Activity, and Cognitive Decline in Older Adults.
Desai P; Dhana K; DeCarli C; Wilson RS; McAninch EA; Evans DA; Rajan KB
JAMA Netw Open; 2022 Mar; 5(3):e223596. PubMed ID: 35315915
[TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light chain level as a predictor of cognitive stage transition.
Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J
Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
